This market has settled: RESOLVED
Settled on March 21, 2026
Will Ivan Demidov win the 2025–2026 NHL Calder Memorial Trophy?
Will Ivan Demidov win the 2025–2026 NHL Calder Memorial Trophy? Odds: 0.3% YES on Polymarket. See live prices and trade this market.
Ivan Demidov Calder Trophy Analysis
Current Odds
| Platform | Yes | No | Volume | Trade |
|---|---|---|---|---|
| Polymarket | 0.3% | 99.7% | $10K | Trade on Polymarket |
Market Analysis
At 0.3% implied probability, the market is pricing Demidov as an extreme longshot for the 2025-2026 Rookie of the Year award, reflecting significant skepticism about his NHL readiness and immediate impact relative to other highly-touted prospects entering the league. This valuation matters now because Demidov is still pre-NHL, making the market heavily dependent on where he lands, his deployment trajectory, and whether he can outpace generational talent like Macklin Celebrini, Connor Bedard’s draft class peers, and other lottery-eligible freshmen.
The bull case hinges on Demidov’s exceptional production in the KHL last season and his skill set—elite playmaking, hockey IQ, and a frame approaching 6’3”—that has drawn comparisons to franchise cornerstones. If he lands with a contender needing immediate scoring depth, logs 15+ minutes nightly, and posts a 60+ point pace as a rookie, he’d crack the Calder conversation. The Montreal Canadiens hold his rights, and deploying him alongside established centermen could unlock scoring-line minutes typically reserved for Calder candidates. A hot start through October-November could dramatically shift sentiment and tighten these odds.
The bear case is substantial: Demidov has never played in North America, faces a significant adjustment curve to the NHL’s pace and physicality, and competes in a class loaded with consensus top-5 picks who have skating and strength advantages. The Habs’ recent emphasis on youth development suggests he may begin in a sheltered role rather than the high-leverage minutes required for Calder contention. Injury, performance struggles in his first 20 games, or a demotion to the AHL would effectively eliminate his candidacy. The 0.3% price already accounts for these baseline risks—movement hinges on preseason tape, opening-week performance, and roster utilization decisions by late September 2025.
Watch October 2025 closely: Demidov’s first five games will reveal whether the Habs deploy him as a scoring threat or ease him in gradually. Monitor ice time trends through November and December alongside point totals; anyone under 0.5 points-per-game or skating under 12 minutes per night post-October should signal declining probability. Compare his trajectory to other European rookie debuts and track injury reports throughout the season, as even a five-game absence could crater already minimal odds.
Related Markets
- Will the Dallas Mavericks win the 2026 NBA Finals? — 0% YES
- Will the Miami Heat win the 2026 NBA Finals? — 1% YES
- Will the Vegas Golden Knights win the 2026 NHL Stanley Cup? — 5% YES
Frequently Asked Questions
What role must Demidov play for his Calder odds to improve meaningfully?
He needs consistent third-line or better deployment (14+ minutes nightly) with primary offensive responsibilities from game one; a purely sheltered fourth-line role makes the award mathematically improbable.
How much does playing for Montreal versus another team impact his candidacy?
Montreal’s rebuilding timeline and reluctance to artificially inflate rookie usage actually hurts his odds—a trade to a contender needing immediate scoring depth would substantially improve his win probability, potentially doubling or tripling these odds.
Are there recent comparable European prospects whose Calder performance can benchmark Demidov’s risk?
Artemi Panarin debuted at age 23 and won the award, while Pavel Zacha and other high-ceiling European rookies disappointed relative to expectations—Demidov’s adjustment timeline is genuinely uncertain and the sub-1% pricing reflects this legitimate execution risk.